Market revenue in 2023 | USD 4,466.3 million |
Market revenue in 2030 | USD 5,454.4 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Pcr-based diagnostics |
Fastest growing segment | NGS DNA Diagnosis |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.92% in 2024. Horizon Databook has segmented the North America dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
Growth in North America can be attributed to the presence of sophisticated healthcare infrastructure, strong government initiatives, proactive funding for DNA testing research, and the high prevalence of chronic diseases.
Furthermore, North America has seen widespread adoption of genetic testing for various purposes, such as disease risk assessment, pharmacogenomics, prenatal screening, and ancestry testing.
The availability of advanced laboratory facilities, favorable reimbursement policies, and a large population base with access to healthcare are expected to contribute to the region's dominance in the DNA diagnostic market.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dna diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account